EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,802 | -34.9% | 2,920 | -43.0% | 0.06% | -29.8% |
| Q2 2023 | $97,939 | -1.5% | 5,125 | 0.0% | 0.08% | -17.6% |
| Q1 2023 | $99,476 | +21.0% | 5,125 | 0.0% | 0.10% | +37.8% |
| Q4 2022 | $82,205 | +2.8% | 5,125 | 0.0% | 0.07% | -1.3% |
| Q3 2022 | $80,000 | +19.4% | 5,125 | +60.2% | 0.08% | +29.3% |
| Q2 2022 | $67,000 | -8.2% | 3,200 | 0.0% | 0.06% | +16.0% |
| Q1 2022 | $73,000 | +25.9% | 3,200 | 0.0% | 0.05% | +42.9% |
| Q4 2021 | $58,000 | -14.7% | 3,200 | 0.0% | 0.04% | -18.6% |
| Q3 2021 | $68,000 | +17.2% | 3,200 | 0.0% | 0.04% | +13.2% |
| Q2 2021 | $58,000 | -38.9% | 3,200 | -23.8% | 0.04% | -42.4% |
| Q1 2021 | $95,000 | +13.1% | 4,200 | 0.0% | 0.07% | +3.1% |
| Q4 2020 | $84,000 | -18.4% | 4,200 | 0.0% | 0.06% | -29.7% |
| Q3 2020 | $103,000 | +119.1% | 4,200 | +110.0% | 0.09% | +97.8% |
| Q2 2020 | $47,000 | -77.7% | 2,000 | -81.4% | 0.05% | -83.2% |
| Q4 2018 | $211,000 | – | 10,725 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |